The experimental shot is also being produced by the Serum Institute of India, the world’s largest manufacturer of vaccines by volume, and AstraZeneca is in talks with several governments and global partners to increase production. Oxford Biomedica said on Thursday it signed a one-year clinical and commercial supply agreement with AstraZeneca to provide multiple batches of the vaccine, called AZD1222, and that the majority of the batches would be produced throughout 2020. Last month, Oxford Biomedica said it joined a consortium, including the Jenner Institute, that came together for possible large-scale manufacturing of AZD1222. …read more
Source:: Yahoo Finance
